Immune response generated with the administration of autologous Dendritic Cells pulsed with an allogenic Tumoral Cell- lines lysate in patients with newly diagnosed diffuse intrinsic pontine glioma

2022-02-23T15:32:29+00:00February 23rd, 2022|

Immune response generated with the administration of autologous Dendritic Cells pulsed with an allogenic Tumoral Cell- lines lysate in patients with newly diagnosed diffuse intrinsic pontine glioma T cell obtained from CFS [...]

Surgery and adjuvant dendritic cell-based tumour vaccination for patients with relapsed malignant glioma, a feasibility study

2022-02-15T08:48:13+00:00February 15th, 2022|

Surgery and adjuvant dendritic cell-based tumour vaccination for patients with relapsed malignant glioma, a feasibility study MRI scan CONTACT US Summary DC loaded with proteins derived from autologous tumour [...]

Modulated Electro-hyperthermia in Integrative Cancer Treatment for Relapsed Malignant Glioblastoma and Astrocytoma- Retrospective Multicenter Controlled Study

2022-01-04T07:21:20+00:00January 4th, 2022|

Modulated Electro-hyperthermia in Integrative Cancer Treatment for Relapsed Malignant Glioblastoma and Astrocytoma- Retrospective Multicenter Controlled Study Magnetic resonance imaging of glioblastoma CONTACT US Summary The study aims to evaluate [...]

Autologous Dendritic Cell Vaccination and Radiochemotherapy following Fluorescence-guided Surgery in Newly Diagnosed Glioblastoma Patients

2022-01-01T13:18:30+00:00January 1st, 2022|

Autologous Dendritic Cell Vaccination and Radiochemotherapy following Fluorescence-guided Surgery in Newly Diagnosed Glioblastoma Patients Overall Survival CONTACT US Summary This study investigates the combination of tumor lysate-pulsed autologous dendritic [...]

Phase III randomized trial of autologous cytokine-induced killer cell immunotherapy for newly diagnosed glioblastoma in korea

2021-12-29T18:31:21+00:00December 29th, 2021|

Phase III randomized trial of autologous cytokine-induced killer cell immunotherapy for newly diagnosed glioblastoma in korea Treatment Scheme CONTACT US Summary The study aims to evaluate the efficacy and [...]

Alpha-type-1 Polarized Dendritic Cell-based Vaccination in Newly Diagnosed High-grade Glioma: A Phase II Clinical Trial

2021-11-22T10:55:34+00:00November 19th, 2021|

Alpha-type-1 Polarized Dendritic Cell-based Vaccination in Newly Diagnosed High-grade Glioma: A Phase II Clinical Trial Change in expression CONTACT US Summary This study examines patients with Glioblastoma multiforme (GBM) [...]

A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma

2021-11-22T10:34:24+00:00November 19th, 2021|

A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma Treatment scheme CONTACT US Summary This study focuses on the [...]

Retrospective observational Clinical Study on Relapsed Malignant Gliomas Treated with Electro-hyperthermia

2021-11-14T08:37:36+00:00November 11th, 2021|

Retrospective observational Clinical Study on Relapsed Malignant Gliomas Treated with Electro-hyperthermia Brain scans CONTACT US Summary This study aims to evaluate the efficacy and tolerability of electro-hyperthermia (ET) for [...]

Go to Top